Understanding the fundamental mechanisms of arbovirus transmission and pathogenesis is 30 essential to develop new strategies for treatment and prevention. We previously took an in vivo 
INTRODUCTION
( Kielian and Rey, 2006) , anchored to the membrane at the C-terminus, and with an ectodomain pathogenesis. In particular, position 80 is fully conserved within the alphavirus genus and is of this variant in vivo and its evolutionary conservation, we hypothesize that this residue is a 116 key determinant for CHIKV transmission and infectivity. However, its molecular mechanisms 117 and function remain unknown.
118
In this study, we aimed to dissect and identify the specific role of the E1 glycoprotein and is genetically constrained in a host-specific manner. We previously identified two 136 variants in the CHIKV E1 glycoprotein, E1-V80I and E1-A129V ( Figure 1A) , that together 137 increased viral transmission and pathogenesis in vivo (Stapleford et al., 2014) . Given the 138 selection of E1-V80I in vivo and its evolutionary conservation, we hypothesize that this residue 139 is a key determinant for CHIKV transmission and infectivity. To investigate the role of residue 140 E1-80 in the CHIKV life cycle, we began by addressing the mutational tolerance of this position.
141
To do this, we took an unbiased mutagenesis approach and changed position 80 to every 142 possible canonical amino acid residue. Because CHIKV alternates between a mammal host 143 and mosquito vector, we generated each variant in baby hamster kidney (BHK-21) and Ae.
144
albopictus (C6/36) cells, passaged the viruses three times over each cell type, and addressed 145 the genetic stability by Sanger sequencing ( Table 1) .
146
In mammalian cells, we found five variants bearing isoleucine (I), glycine (G), alanine
147
(A), leucine (L) and glutamine (Q) substitutions (V80I, G, A, L, and Q) to be genetically stable 148 with the majority of these mutations being aliphatic, similar to the wildtype valine residue (V80).
149
In addition, the unstable mutants did not all revert to wildtype (Table 1 and Supplemental
150
Figure 1) but in some cases changed to a stable variant or acquired second-site mutations 151 including E1-A129V which we have previously identified in vivo (Stapleford et al., 2014) 152 providing further evidence that these residues are functionally and genetically linked. implicated with CHIKV fusion and cholesterol dependence suggesting a potential functional link between position 80 and these residues in these processes (Lu et al., 1999; Tsetsarkin et 163 al., 2011; Vashishtha et al., 1998) . Finally, it should be noted that with exception of mutation 164 E1-A129V, none of these mutations were observed in passages performed in mammalian cells 165 (Table 1 
179
We transfected BHK-21 cells with each viral RNA and measured luciferase expression at 4, 6 180 and 8 hours post-transfection (Supplementary Figure 2B) . We confirmed that the luciferase 181 levels measured in the early time points (4 and 6 hours) are strictly associated to viral 182 replication as infectious virus cannot be detected until 8 hours post-transfection
183
(Supplementary Figure 2B) . We used a non-replicative nsP4 active site polymerase mutant 0.01 on both mammalian (BHK-21 and human foreskin fibroblasts (HFF-1)) and insect (C6/36
190
and Ae. aegypti (Aag2)) cells. We found that the E1-V80L and E1-V80Q substitutions
191
significantly attenuated viral production in mammalian ( Figure 1D ) and mosquito cell lines
192
( Figure 1E) 
224
To address the impact of the variant E1-V80Q, for which we were unable to obtain high 225 titer stocks, we infected mosquitoes with a low-dose of each virus (10 4 PFU/ml) and allowed
226
the infections to progress for 14 days. We found that at low doses, the variants had a trend 
230
V80Q ( Figure 1C ) we found that viruses isolated from two mosquitoes reverted in plaque size
231
(Supplementary Figure 3A) . We Sanger sequenced the full viral structural region from these 232 two mosquitoes and found that in addition to the E1-V80Q mutation, each individual virus 233 acquired an additional second-site mutation in the E1 glycoprotein: E1-N20Y or E1-M88L
234
(Supplementary Figure 3A) . Both residues E1-20 and E1-88 are located in regions implicated 235 in modulation of viral fusion (Voss et al., 2010; Zheng et al., 2011) , suggesting that the 236 attenuation observed for these mutants could be associated to a defect in fusion
237
(Supplementary Figure 3B and 3C) . Importantly, of all the mosquitoes infected with E1-
238
V80Q, including the ones with reversion in their plaque phenotype, none were able to 239 disseminate into the legs and wings and this effect was also observed for E1-V80L although 240 less pronounced ( Figure 2B ). 
248
C57BL/6J mice with 1000 PFU of E1-V80, V80A, V80L, and V80Q in the left footpad and
249
addressed infectious viral loads and dissemination two days post infection which has been 250 described as the peak of viremia of CHIKV for this model (Gardner et al., 2010 ) ( Figure 3A ).
251
Interestingly, we found reduced levels of E1-V80L in the ipsilateral muscle ( Figure 3B ), a 252 primary site of infection, as well as in the spleen and liver ( Figure 3C ), secondary sites of 253 infection. Strikingly, we were unable to recover infectious E1-V80L particles from the heart and 254 brain of infected mice indicating that this virus was significantly impaired in dissemination to 255 specific organs ( Figure 3C , lower panel). On the other hand, we found that the E1-V80Q
256
variant had reduced titers at the site of injection ( Figure 3B ) and we did not detect infectious 257 virus in the serum or other secondary organs suggesting a strong restriction of this virus to the 258 site of injection ( Figure 3C ).
259
One possible explanation for the restriction in dissemination, especially for the E1-
260
V80Q variant is that the virus was not able to replicate in the injection site therefore not able 
282
To test this hypothesis, we generated ZsGreen reporter viruses of E1-V80, V80L, V80Q
283
and V80A to visualize infected cells and preformed cellular binding and fusion assays
284
(Supplementary Figure 2A) infection. We found that while cholesterol depletion had no effect on the E1-V80A infectivity 317 compared to wildtype, E1-V80L was significantly affected by this treatment ( Figure 4C ),
318
indicating that this attenuated variant has increased cholesterol dependence. In order to 319 confirm that the reduced infectivity observed for E1-V80L in the presence of MbCD was due 320 to the effect of cholesterol, we replenished BHK-21 depleted cells with 200 μg/ml of cholesterol.
321
We found that upon replenishment of membrane cholesterol, E1-V80L infectivity was restored
322
( Figure 4D ), indicating that residue E1-80 is involved in CHIKV cholesterol dependence.
324
E1 residues 80 and 226 function together in CHIKV infectivity and dissemination.
325
Position E1-226 has been shown to modulate the cholesterol requirement for CHIKV, SFV and
326
SINV viral entry (Lu et al., 1999; Tsetsarkin et al., 2011; Vashishtha et al., 1998) . Given the (Table 1 and Supplementary figure 1B), and that E1-V226A substitution in CHIKV IOL V80L cholesterol dependence, providing a functional link between these two residues. To test
332
this hypothesis, we first introduced the E1-V226A mutation in our E1-V80L infectious clone, 333 generated the double mutant virus (E1-V80L:V226A) and confirmed stability after three 334 passages on BHK-21 cells. We found that the E1-V80L:V226A variant showed an increased 335 plaque size compared to E1-V80L ( Figure 5A ), suggesting that this mutation rescued the 336 impaired viral spreading observed for E1-V80L. We next addressed the capacity of E1-
337
V80L:V226A to restore E1-V80L reduced infectivity in cholesterol-depleted cells. Indeed, we
338
found that the E1-V80L:V226A variant reduced the cholesterol dependence observed for E1-
339
V80L (Figure 5B), confirming that both residues E1-80 and 226 are involved in this process.
340
Finally, we asked whether the E1-V226A substitution is able to rescue the E1-V80L in vivo 341 attenuation and dissemination phenotype observed in mice. For that purpose, we infected
342
C57BL/6J mice via footpad injection with ~1000 PFU of E1-V80, V80L or V80L:V226A variants.
343
We found that E1-V80L:V226A double mutant rescued the attenuated phenotype observed for
344
E1-V80L in primary organs ( Figure 5C ). Interestingly, our results also indicate that the E1-
345
V80L:V226A double mutant rescued the dissemination phenotype observed in the heart and 346 the brain ( Figure 5D ), suggesting functional link between these two residues. Taken together,
347
these results demonstrate that the highly conserved position 80 in the E1 glycoprotein is a key 
431
Finally, we showed that in adult C57BL/6, both the E1-V80L and V80Q variants had 432 impaired dissemination to secondary organs compared to wildtype CHIKV ( Figure 3) ; the IFNAR signaling pathway (York et al., 2015 
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V, 550 μF, with a resistance of 25W. Cells were allowed to recover for 10 min at room 758 temperature, transferred into 6 ml of warm DMEM, and placed in a T25 flask at 37 ºC for 72 h.
759
Virus was harvested, clarified at 1,200 x g for 5 min, and 3 ml of the clarified supernatants determined by plaque assay. 
781
washed two times with PBS, and 100 μl of complete media was added to each well.
782
Luminescence was quantified after 24 hours as described above.
784
Viral growth curves and extracellular RNA levels. 
